Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Ikle

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 11, 2020
Challenges of calcineurin inhibitor withdrawal following combined pancreas and kidney transplantation: Results of a prospective, randomized clinical trialPeter G Stock, Roslyn B Mannon, Brian Armstrong, et al.
Transplantation|May 12, 2021
Serum MicroRNA Transcriptomics and Acute Rejection or Recurrent Hepatitis C Virus in Human Liver Allograft Recipients: A Pilot StudyThangamani Muthukumar, Kemal M Akat, Hua Yang, et al.
Hepatology (Baltimore, Md.)|June 16, 2016
Five-year histological and serological follow-up of operationally tolerant pediatric liver transplant recipients enrolled in WISP-RSandy Feng, Anthony J Demetris, Katharine M Spain, et al.
Journal of the American College of Cardiology|July 6, 2019
Accelerated Allograft Vasculopathy With Rituximab After Cardiac TransplantationRandall C Starling, Brian Armstrong, Nancy D Bridges, et al.
Pediatric Transplantation|June 23, 2017
Epstein-Barr viral loads do not predict post-transplant lymphoproliferative disorder in pediatric lung transplant recipients: A multicenter prospective cohort studyAndrew Parrish, Matthew Fenchel, Gregory A Storch, et al.
JAMA|January 19, 2012
Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplantsSandy Feng, Udeme D Ekong, Steven J Lobritto, et al.
Journal of the American Society of Nephrology : JASN|November 9, 2014
Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvementDuvuru Geetha, Ulrich Specks, John H Stone, et al.
Journal of the American Society of Nephrology : JASN|May 1, 2015
Adverse Outcomes of Tacrolimus Withdrawal in Immune-Quiescent Kidney Transplant RecipientsDonald E Hricik, Richard N Formica, Peter Nickerson, et al.
Annals of the Rheumatic Diseases|December 2, 2015
Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA typeSebastian Unizony, Miguel Villarreal, Eli M Miloslavsky, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 8, 2016
Cholesterol efflux capacity of high-density lipoprotein correlates with survival and allograft vasculopathy in cardiac transplant recipientsAli Javaheri, Maria Molina, Payman Zamani, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 11, 2020
Challenges of calcineurin inhibitor withdrawal following combined pancreas and kidney transplantation: Results of a prospective, randomized clinical trialPeter G Stock, Roslyn B Mannon, Brian Armstrong, et al.
Transplantation|May 12, 2021
Serum MicroRNA Transcriptomics and Acute Rejection or Recurrent Hepatitis C Virus in Human Liver Allograft Recipients: A Pilot StudyThangamani Muthukumar, Kemal M Akat, Hua Yang, et al.
Hepatology (Baltimore, Md.)|June 16, 2016
Five-year histological and serological follow-up of operationally tolerant pediatric liver transplant recipients enrolled in WISP-RSandy Feng, Anthony J Demetris, Katharine M Spain, et al.
Journal of the American College of Cardiology|July 6, 2019
Accelerated Allograft Vasculopathy With Rituximab After Cardiac TransplantationRandall C Starling, Brian Armstrong, Nancy D Bridges, et al.
Pediatric Transplantation|June 23, 2017
Epstein-Barr viral loads do not predict post-transplant lymphoproliferative disorder in pediatric lung transplant recipients: A multicenter prospective cohort studyAndrew Parrish, Matthew Fenchel, Gregory A Storch, et al.
JAMA|January 19, 2012
Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplantsSandy Feng, Udeme D Ekong, Steven J Lobritto, et al.
Journal of the American Society of Nephrology : JASN|November 9, 2014
Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvementDuvuru Geetha, Ulrich Specks, John H Stone, et al.
Journal of the American Society of Nephrology : JASN|May 1, 2015
Adverse Outcomes of Tacrolimus Withdrawal in Immune-Quiescent Kidney Transplant RecipientsDonald E Hricik, Richard N Formica, Peter Nickerson, et al.
Annals of the Rheumatic Diseases|December 2, 2015
Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA typeSebastian Unizony, Miguel Villarreal, Eli M Miloslavsky, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 8, 2016
Cholesterol efflux capacity of high-density lipoprotein correlates with survival and allograft vasculopathy in cardiac transplant recipientsAli Javaheri, Maria Molina, Payman Zamani, et al.
Pageof 3